P&T considerations in fashioning a knowledge base, action plan for cardiometabolic disorders and weight; Focus on golimumab; Drug Watch: Agents in late-stage development for the treatment of gastrointestinal disorders

Get the latest industry news, event updates, and more from Managed healthcare Executive.

Subscribe Now!

Formulary Digital Edition September 2009

Newsletter